Qube Research & Technologies (QRT)’s Acumen Pharmaceuticals ABOS Stock Holding History
Bought
Maintained
Sold
Other funds holding ABOS
Qube Research & Technologies (QRT)'s ABOS Position: Q3 2026 in Review
Qube Research & Technologies (QRT) sold out of Acumen Pharmaceuticals (ABOS) in Q3 2026, closing a stake of 38,614 shares — an estimated $103K sold.
Qube Research & Technologies (QRT) first reported a position in ABOS in Q2 2022 and held it in 16 quarters. The position peaked at $679K in Q1 2024. 95 funds tracked by Wall St. Rank hold ABOS as of Q3 2026.
- Qube Research & Technologies (QRT) reported no remaining Acumen Pharmaceuticals position as of Q3 2026 after selling out during the quarter.
- Qube Research & Technologies (QRT) sold 38,614 Acumen Pharmaceuticals shares in Q3 2026, an estimated $103K.
- Qube Research & Technologies (QRT) first reported a position in Acumen Pharmaceuticals in Q2 2022 and held it in 16 quarters.
- Qube Research & Technologies (QRT)'s Acumen Pharmaceuticals position peaked at $679K in Q1 2024.
- 95 funds tracked by Wall St. Rank held Acumen Pharmaceuticals as of Q3 2026.
Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2026, filed 13 Nov 2026.